Emmaus Life Sciences Reports Financial Results for the Six Months Ended June 30, 2021

TORRANCE, Calif.: TORRANCE, Calif., Sept. 2, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced financial results for the six months ended June 30, 2021. As a result, the company is now current in its...

Click to view original post